Immunohistochemical Staining forChlamydia pneumoniaeIs Increased in Lung Tissue from Subjects with Chronic Obstructive Pulmonary Disease
- 1 September 2000
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 162 (3) , 1148-1151
- https://doi.org/10.1164/ajrccm.162.3.9912134
Abstract
The seroprevalence of Chlamydia pneumoniae is increased in chronic obstructive pulmonary disease (COPD), and subjects with COPD are more likely to have a positive polymerase chain reaction for C. pneumoniae in their sputum. It has been suggested that C. pneumoniae may have a role in the pathogenesis of COPD. We undertook immunohistochemistical staining for C. pneumoniae in archival tissue from subjects who had undergone lobectomy for bronchial carcinoma. There were 16 subjects with COPD (FEV1 = 64 ± 8% [mean ± SD] predicted) and 21 subjects with normal lung function (FEV1 = 95 ± 11% predicted). There was no difference between the two groups in age or smoking history. Tissues from all of the subjects stained positively for C. pneumoniae, but in the subjects with COPD there were 14.5 positive cells per field (magnification × 400), as compared with 9.3 cells per field in the control subjects (p = 0.02). Fifty-four percent of the macrophages from the subjects with COPD stained positively for C. pneumoniae, as compared with 29% from the control subjects (p < 0.001). A second control group consisted of 18 younger individuals (mean age: 32 yr) who died accidentally. Only 44% of these subjects had positive staining for C. pneumoniae, and the mean number of cells per field was 0.4. These findings suggest that persistent infection with C. pneumoniae is common, and that there is increased immunostaining for C. pneumoniae in COPD. Further studies are necessary to determine whether chronic infection with C. pneumoniae is important in the pathogenesis of COPD.Keywords
This publication has 15 references indexed in Scilit:
- Chlamydia pneumoniaeand its role in chronic obstructive pulmonary diseaseAnnals of Medicine, 1998
- Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.American Journal of Respiratory and Critical Care Medicine, 1997
- Increased incidence of Chlamydiaspecies within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseaseJournal of the American College of Cardiology, 1996
- Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.American Journal of Respiratory and Critical Care Medicine, 1996
- Further Characterization of Chlamydia pneumoniae Specific Monoclonal AntibodiesMicrobiology and Immunology, 1995
- Experimental infection of Chlamydia pneumoniae in miceMicrobial Pathogenesis, 1993
- Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary ArteriesThe Journal of Infectious Diseases, 1993
- Latent Adenoviral Infection in the Pathogenesis of Chronic Airways ObstructionAmerican Review of Respiratory Disease, 1992
- Chlamydia pneumoniae, Strain TWAR, Infection in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Review of Respiratory Disease, 1991
- A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990